Fundraising FoxAkero Therapeutics, Inc.
South San Francisco, US · Founded 2017 · 2 known investors
Find your way into Akero Therapeutics, Inc.
Sign up to see every warm intro you have to Akero Therapeutics, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Akero Therapeutics, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Akero Therapeutics, Inc. was founded in 2017 by Andrew Cheng.
AC
Andrew ChengFounder
JY
Jonathan YoungExecutiveJonathan Young holds senior executive positions spanning biotechnology drug development, law, and policy across private industry, government, and nonprofit sectors. He is an executive officer at Akero Therapeutics, Inc.
Board
AK
Aaron KantoffBoard director
AR
GW
Graham WalmsleyBoard director
KB
MI
Mark IwickiBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$45.5M disclosed across 1 round · 2018
▶$45.5MraisedDec 2018 · 20 investors · Other Health CareRule 506(b)
▶$45.5MraisedDec 2018 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Aaron KantoffDirector
- Aaron RoystonDirector
- Mark IwickiDirector
- Graham WalmsleyDirector
- Jonathan YoungExecutive Officer
- Kevin BittermanDirector
- Andrew ChengExecutive Officer, Director
- Offering amount
- $45.5M
- Amount sold
- $45.5M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Akero Therapeutics, Inc.?
- Akero Therapeutics, Inc. was founded by Andrew Cheng in 2017.
- Who are Akero Therapeutics, Inc.'s investors?
- Akero Therapeutics, Inc.'s investors include Atlas Venture, venBio Partners.
- How much funding has Akero Therapeutics, Inc. raised?
- Akero Therapeutics, Inc. has disclosed $45.5M raised across 1 round.
- Where is Akero Therapeutics, Inc. headquartered?
- Akero Therapeutics, Inc. is headquartered in South San Francisco, US.